14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Pulmonary Hypertension in 2 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kandhi, S | 2 |
| Froogh, G | 2 |
| Qin, J | 2 |
| Luo, M | 2 |
| Wolin, MS | 2 |
| Huang, A | 2 |
| Sun, D | 2 |
| Jiang, H | 1 |
2 other studies available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Pulmonary Hypertension
| Article | Year |
|---|---|
EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arterial Pressure; Disease Models, Animal; Dose-Response Relat | 2016 |
EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8,11,14-Eicosatrienoic Acid; Ani | 2015 |